We are live on ! Find out more
WST icon

West Pharmaceutical
WST

638 hedge funds and large institutions have $16.9B invested in West Pharmaceutical in 2022 Q3 according to their latest regulatory filings, with 74 funds opening new positions, 246 increasing their positions, 221 reducing their positions, and 83 closing their positions.

New
Increased
Maintained
Reduced
Closed

104% more call options, than puts

Call options by funds: $38.3M | Put options by funds: $18.8M

11% more repeat investments, than reductions

Existing positions increased: 246 | Existing positions reduced: 221

0.82% more ownership

Funds ownership: 91.88% → 92.7% (+0.82%)

3% less funds holding

Funds holding: 655 → 638 (-17)

11% less first-time investments, than exits

New positions opened: 74 | Existing positions closed: 83

18% less capital invested

Capital invested by funds: $20.6B → $16.9B (-$3.69B)

30% less funds holding in top 10

Funds holding in top 10: 10 → 7 (-3)

Holders
638
Holders Change
-17
Holders Change %
-2.6%
% of All Funds
10.99%
Holding in Top 10
7
Holding in Top 10 Change
-3
Holding in Top 10 Change %
-30%
% of All Funds
0.12%
New
74
Increased
246
Reduced
221
Closed
83
Calls
$38.3M
Puts
$18.8M
Net Calls
+$19.5M
Net Calls Change
-$4.27M

Top Buyers

Rank Fund Capital Flow
1
Bank of New York Mellon
Bank of New York Mellon
New York
+$153M
2
Brown Advisory
Brown Advisory
Maryland
+$72M
3
DCP
Durable Capital Partners
Maryland
+$56.5M
4
Amundi
Amundi
France
+$42.3M
5
Millennium Management
Millennium Management
New York
+$41.2M

Top Sellers

Rank Fund Capital Flow
1
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
-$724M
2
Massachusetts Financial Services
Massachusetts Financial Services
Massachusetts
-$88.6M
3
IIM
INTECH Investment Management
Florida
-$56.5M
4
Invesco
Invesco
Georgia
-$56.1M
5
Franklin Resources
Franklin Resources
California
-$35.1M
Name Holding Trade Value Shares
Change 		Change in
Stake
WPA
701
West Paces Advisors
Georgia
– -$11.5K -38 Closed
BMD
702
Better Money Decisions
New Mexico
– -$9K -30 Closed
SC
703
Siena Capital
Ohio
– -$8K -25 Closed
STCOSD
704
Sageworth Trust Company of South Dakota
South Dakota
– -$6K -21 Closed
PMFA
705
Plante Moran Financial Advisors
Michigan
– -$5K -15 Closed
SFG
706
Steward Financial Group
Texas
– -$4K -14 Closed
CWP
707
Concord Wealth Partners
Virginia
– -$4K -13 Closed
AAP
708
Arax Advisory Partners
Colorado
– -$4K -12 Closed
VVP
709
Venture Visionary Partners
Ohio
– -$3.63K -12 Closed
TIM
710
Tevis Investment Management
Texas
– -$3K -10 Closed
MFT
711
Moisand Fitzgerald Tamayo
Florida
– -$2K -8 Closed
UFF
712
USA Financial Formulas
Michigan
– -$1.83K -6 -75%
PFGIA
713
Patriot Financial Group Insurance Agency
Massachusetts
– -$1K -4 Closed
TWP
714
TFO Wealth Partners
Ohio
– -$1K -3 Closed
MBFW
715
Morton Brown Family Wealth
Pennsylvania
– -$1K -2 Closed
CYG
716
Clean Yield Group
Vermont
– +$609 +2 New
25 26 27 28
29

WST Hedge Fund Activity: Q3 2022 in Review

638 of the 5,805 institutional investors tracked by Wall St. Rank reported a position in West Pharmaceutical (WST) for Q3 2022, worth a combined $16.9B — down 18% from $20.6B a quarter earlier.

Sellers outnumbered buyers: 83 funds closed out of WST and 74 opened new positions — a net loss of 9 holders — while 221 trimmed existing stakes and 246 added.

The largest buyer was Bank of New York Mellon, adding an estimated $153M. The largest seller was T. Rowe Price Associates, cutting an estimated $724M.

  • 638 institutional investors held West Pharmaceutical (WST) as of Q3 2022, down from 655 in Q2 2022.
  • Funds reported $16.9B of West Pharmaceutical stock for Q3 2022, down 18% quarter-over-quarter.
  • 74 funds opened new West Pharmaceutical positions in Q3 2022 and 83 closed out, a net change of -9 holders.
  • The largest West Pharmaceutical buyer in Q3 2022 was Bank of New York Mellon, an estimated $153M added.
  • The largest West Pharmaceutical seller in Q3 2022 was T. Rowe Price Associates, an estimated $724M sold.

Based on aggregated 13F filings for Q3 2022.